Skip to main content

Animations

MJFF Publications

491 - 500 of 6433 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Kinase Domain Is a Dynamic Hub for Driving LRRK2 Allostery
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2020.538219
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease Research
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2020.00524
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Parkinson's Disease Research on the African Continent: Obstacles and Opportunities
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2020.00512
    Citation Count: 34
  • Summary Details
    OPEN
    Title: LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00577
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Editorial: Protein Degradation Pathways in Parkinson's Disease and Neurodegeneration
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00741
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Disclosure of individual research results at federally funded Alzheimer's Disease Research Centers
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12213
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A)
    Journal Name: American Journal of Medical Genetics Part A
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ajmg.a.62437
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of life
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51424
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51402
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51358
    Citation Count: 16
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.